I am a breastfeeding mother and i want to know if it is safe to use EINECS 234-118-0? Is EINECS 234-118-0 safe for nursing mother and child? Does EINECS 234-118-0 extracts into breast milk? Does EINECS 234-118-0 has any long term or short term side effects on infants? Can EINECS 234-118-0 influence milk supply or can EINECS 234-118-0 decrease milk supply in lactating mothers?
- DrLact safety Score for EINECS 234-118-0 is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of EINECS 234-118-0 may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that EINECS 234-118-0 may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using EINECS 234-118-0 .
- Usage of EINECS 234-118-0 is in contradiction to breastfeeding hence if it is must to use EINECS 234-118-0 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Anti-estrogen drug with anticancer effects. May inhibit lactation. It is not safe for the mother to continue BF whenever a risk of residual tumor is likely, which actually has been the reason for using this drug. Once any risk had disappeared (later on, or after a future pregnancy) it is convenient to resume BF.
Since EINECS 234-118-0 can suppress postpartum lactation and its excretion into breastmilk is not known, it should be avoided in nursing mothers.
EINECS 234-118-0 was more effective than placebo in suppressing lactation and preventing engorgement and pain in two trials in postpartum mothers. Neither study stated what, if any, physical methods (e.g., breast binding) were used concurrently.[1][2] In one study of 80 women, EINECS 234-118-0 10 mg four times daily for 5 days was more effective than placebo in suppressing a rise in serum prolactin after use of a mechanical breast pump after 5 days of treatment, but not on day 3. All of the women in the study had breastfed a previous child.[2] The other study of 150 women used 2 regimens: EINECS 234-118-0 30 mg twice daily for 2 days followed by 10 mg twice daily for 2 days; and 10 mg twice daily for 14 days. More women in the EINECS 234-118-0 groups had not previously breastfed an infant.[1] In a case report, a woman with a history of breastfeeding 4 children (the last having been weaned 10 months earlier) began lactating after 1 week of a cancer chemotherapy regimen for breast cancer that included EINECS 234-118-0 20 mg/day. Milk production continued for several weeks until EINECS 234-118-0 was discontinued after which it did not return during 12 more weeks of chemotherapy.[3]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.